Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

ADAMTS-17 Activators

Disintegrin and Metalloproteinase with Thrombospondin Motifs (ADAMTS) enzymes are a family of secreted metalloproteases that play critical roles in the remodeling and homeostasis of the extracellular matrix (ECM). ADAMTS-17 is one of the members of this family, participating in the breakdown of a variety of ECM components such as proteoglycans, collagens, and other matrix constituents. Unlike membrane-anchored ADAMs, ADAMTS enzymes are secreted and hence act in the extracellular space. The regulation of ADAMTS-17 is multi-faceted, influenced by various factors including gene expression, substrate availability, and modulation by other signaling pathways. Epigenetic changes, such as DNA methylation or histone modification, can also influence the expression of ADAMTS-17, as can specific growth factors and cytokines that operate through complex signaling networks.

ADAMTS-17 activators might work indirectly by inhibiting pathways that normally suppress ADAMTS-17 activity or by altering the epigenetic landscape to favor gene expression. They might also operate by modulating the availability of substrates within the ECM, which ADAMTS-17 acts upon, or by stabilizing the ECM structure itself. Molecules that act as Reactive Oxygen Species (ROS) scavengers could influence the oxidative environment, potentially supporting optimal enzyme activity. Other molecules may interfere with competing pathways, such as Notch or TGF-β signaling, to fine-tune the activity levels of ADAMTS-17. Overall, the chemical biology of ADAMTS-17 activators is complex, necessitating multi-disciplinary approaches to fully elucidate the mechanisms involved.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

A derivative of vitamin A that can modulate gene expression and thereby potentially affect ADAMTS levels or activity.

Heparin

9005-49-6sc-507344
25 mg
$119.00
1
(0)

This glycosaminoglycan can interact with some ADAMTS proteins and influence their activity.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

Phorbol Esters can upregulate the expression of some ADAMTS proteins, although they are mainly used experimentally.

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$82.00
$216.00
$416.00
48
(1)

A TGF-β inhibitor that can potentially upregulate certain ADAMTS enzymes by suppressing TGF-β signaling pathways that may downregulate ADAMTS expression.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

An HDAC inhibitor that may facilitate ADAMTS gene expression by altering the epigenetic landscape.

GM 6001

142880-36-2sc-203979
sc-203979A
1 mg
5 mg
$77.00
$270.00
55
(1)

An MMP inhibitor that may help in maintaining the ECM substrates available for ADAMTS activity, thus potentially indirectly activating it.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

PDGF Small Molecule Inhibitors could potentially influence ADAMTS activity by interfering with growth factor-mediated ECM remodeling.

Sunitinib, Free Base

557795-19-4sc-396319
sc-396319A
500 mg
5 g
$153.00
$938.00
5
(0)

PDGF Small Molecule Inhibitors could potentially influence ADAMTS activity by interfering with growth factor-mediated ECM remodeling.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

PDGF Small Molecule Inhibitors could potentially influence ADAMTS activity by interfering with growth factor-mediated ECM remodeling.

Esculetin

305-01-1sc-200486
sc-200486A
1 g
5 g
$44.00
$212.00
7
(1)

A naturally occurring coumarin that has been shown to inhibit LOX activity. Lysyl oxidase (LOX) inhibitors target the enzyme responsible for cross-linking collagen and elastin fibers in the extracellular matrix (ECM) and stabilize the ECM, affecting the substrate availability for ADAMTS.